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Objectives: This study was conducted to determine the clinical risk factors for the development of leg length discrepancy
(LLD) in patients with congenital vascular malformation (CVM) affecting the lower extremity.
Methods: A retrospective analysis was conducted of a prospectively collected database that included 361 patients who
underwent assessment of a CVM lesion from September 1994 to January 2005. We measured LLD using lower extremity
scanograms of 229 patients who were suspected of having LLD on physical examination. The risk factor analysis for a
clinically significant LLD (>2 cm) was performed with the variables of age, gender, features of CVM (type, extent and
depth), and the deep vein status (agenesis, hypoplasia, phlebectasia) of the affected limb. Fisher’s exact test and the 2 test
were used for the univariate analysis, and a logistic regression test was performed for the multivariate analysis. Among the
patients with LLD, we compared the overgrowth group and undergrowth group with the Fisher’s exact test to identify
differences between the two subgroups.
Results: The included patients were 153 males (42%) and 208 females (57%) with a mean age of 20  14 years (range, 1
to 62). There were 157 patients (43%) in the still growing age group (age <15 years) and 204 (57%) were in the finished
growing age group (age >15 years). The types of CVMs included 215 venous (60%), 43 arteriovenous (12%), 46
lymphatic (13%), and 57 (16%) combined venolymphatic malformations. On the lower extremity scanogram, 26 patients
(7%) had a LLD of >2 cm due to overgrowth (n  20) or undergrowth (n  6) of the affected limbs. The univariate
analysis showed that a venolymphatic malformation (P  .003) and a whole leg CVM (P  .000) were significant risk
factors for development of LLD. However, the multivariate analysis identified the whole leg CVM lesion as a single
independent risk factor for LLD (P  .004; odds ratio, 6.512, 95% confidence interval, 1.788 to 23.713). On subgroup
analysis, a whole leg CVMwas also identified as a risk factor for overgrowth of the affected limb. In a comparison between
two subgroups of LLD (overgrowth v. undergrowth), overgrowth was significantly (P  .022) more common in female
than in male patients.
Conclusions: As a clinical risk factor for development of LLD, the extent of the CVM lesion was a single independent risk
factor regardless of the type or depth of the CVM lesion. In addition, our data suggest that overgrowth or undergrowth
of the affected limb, as a cause of LLD, might be related to gender. ( J Vasc Surg 2006;44:545-53.)Leg length discrepancy (LLD) has been reported as a
sequela of congenital vascular malformations (CVM) af-
fecting the lower extremity and may result in disfigure-
ment, gait disturbance, pelvic tilting, scoliosis, or back
pain.1,2 In the general population, the prevalence of LLD
2 cm has been reported to be 40% to 70%.3-5 In contrast,
LLD 2 cm has been reported to be very rare.6 In addition,
the reported prevalence of LLD varies according to the
definition and methods of assessment, and various cutoff
points have been used as criteria for surgical or nonsurgical
intervention of LLD by orthopedic surgeons.7,8 Recently,
Vitale et al9 reported a relationship between the length of
LLD and health-related quality of life using data from
lower extremity scanograms and Child Health Question-
naires. According to these investigators, a LLD2 cm was
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LLD in patients with lower extremity CVM can be
caused by both overgrowth and undergrowth of the af-
fected limb, and their prognosis has rarely been reported in
a long-term follow-up study.10 The clinical risk factors
associated with LLD in patients with lower extremity CVM
have also not yet been well described. The purpose of this
study was therefore to determine the factors associated with
clinically significant LLD in patients with lower extremity
CVM.
MATERIAL AND METHODS
Patient recruitment. During a period of 10 years and
4 months, from September 1994 to January 2005, 525
patients with lower extremity CVMwere registered into the
database of a specialized CVM clinic at Samsung Medical
Center, Sungkyunkwan University Medical School. Among
them, 361 patients completed routine studies for assess-
ment of type, extent, and depth of the CVM lesion and
were included in this study. Excluded were 164 patients
who had an incomplete evaluation (n  145) or bilateral
leg involvement (n  19). After institutional review com-
mittee approval, the database of 361 patients was retrospec-
tively analyzed.
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tremity CVM, we performed whole body blood pool scans
(WBBPS) with radionuclide (red blood cells labeled with
technetium Tc 99m),11 magnetic resonance imaging (MRI)
(Sigma Horizon 1.5T, GEMedical, Milwaukee, Wisc) of the
lower extremity, and pelvis and duplex ultrasonography
(Ultramark 9, ATL Inc, Bothell, Wash) of the arteries and
veins of the affected limb as a routine workup. Contrast
or computed tomography (CT) arteriography, ascending
venography, radionuclide (99mTc antimony sulfide colloid)
lymphoscintigraphy, or trans-arterial lung perfusion scin-
tigraphy (TLPS)12 were performed selectively according to
the clinical features and compliance of patients.
The results from these studies were used to categorize
CVM into four groups according to the Hamburg classifica-
tion13: arteriovenous malformation (AVM), venous malfor-
mation (VM), lymphatic malformation (LM), and combined
venolymphatic malformations (VLM). For the diagnosis of
type of CVM, clinical features were considered as well as the
imaging studies.
A CVM lesion with the arteriographic findings of early
venous filling and an enlarged feeding artery was diagnosed
as an AVM even with no apparent arteriovenous fistula
Fig 1. Extent of the congenital vascular malformation
arteriovenous malformation in the left upper leg.B, Lym
right lower leg.C,Magnetic resonance image of venousm
blood pool scan in a patient with venous malformation ton angiogram. In 176 lower extremity CVM lesions witha suspected AVM but without these definitive signs,
TLPSs were performed to ascertain the presence of mi-
croarteriovenous shunting. For TLPS, dynamic images
of the lung were acquired after intravenous injection of
99mTc MAA (185 MBq). At 1 to 2 minutes after intra-
venous injection, 99mTc MAA (185 MBq) was injected
into the proximal femoral artery of the affected limb.
Dose-corrected shunt fraction was calculated from the
time activity curve of the lung. When an AVM lesion was
combined with other types of CVM, we classified it as an
AVM for this study.
For the diagnosis of LM, radionuclide lymphoscintig-
raphy, MRI, or a combination were used as well as the clinical
features of LM such as nonpitting edema, recurrent episodes
of cellulitis, cutaneous lymphatic fistula, pseudoverrucous hy-
perplasia, or lymphangiectasias.14
VM was defined as slow-flow, pure venous component
CVM with or without a port-wine spot on the skin (capil-
lary malformation) and was diagnosed with MRI, duplex
ultrasonography, and WBBPS. VLM was defined as a com-
bined form of CVM composed of VM and LM.
The extent of the CVM lesion was also evaluated using
WBBPS, MRI, and duplex ultrasonography and was cate-
n. A, A computed tomography arteriogram shows an
intigram in a patient with lymphatic malformation in the
mation that involves the left whole leg.D,Awhole-body
volves the left whole leg.lesio
phosc
alforgorized into upper or lower leg involvement and whole leg
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lesion was categorized into subcutaneous, muscle, and
bone involvement. A CVM lesion that involved the knee or
ankle joint was examined as a separate variable from the
above-described categories (Fig 2). Finally, an association
with deep venous abnormalities was examined using duplex
ultrasonography and MRI from the iliac to the popliteal
vein of the affected limb.
Ascending venography was performed only in the early
phase of this study and was more recently replaced by
duplex ultrasonography. A deep venous abnormality was
Fig 2. Depth of congenital vascular malformation lesion
involves the subcutaneous tissue of thigh. B, A venolym
tissue. C, An arteriovenous malformation involves the
involves the knee joint.
Fig 3. Associated deep venous abnormalities in patien
venogram shows aplasia of left femoral vein (arrow). B,U
aneurysmal dilatation of the popliteal vein (arrow).defined as aplasia (not detectable venous flow in a segmentof deep vein), hypoplasia (diameter of a segment of deep
vein 50% of adjacent vein diameter), and phlebectasia
(diameter of a segment of deep vein  200% of adjacent
vein diameter) (Fig 3).
Measurement of leg length discrepancy. The initial
assessment of LLD began with the physical examination. In
the standing position on a flat floor, symmetry of the gluteal
folds and transverse popliteal skin creases of both legs were
inspected as well as other findings such as pelvic tilting,
scoliosis, and leg or foot deformities. In younger children,
we examined patients in the supine position on a firm, flat
agnetic resonance imaging. A, A venous malformation
malformation involves thigh muscle and subcutaneous
muscle and femur bone. D, A venous malformation
th congenital vascular malformation. A, An ascending
onogram shows popliteal vein phlebectasia, a segmentalon m
phatic
thights wi
ltrassurface, with the feet held in a flat plane on the examining
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mination of whether the femur or tibia of the affected limb
was longer or shorter than the opposite one was done
(Galeazzi’s test).
For the 229 patients suspected of having LLDon physical
examination, lower extremity scanograms were performed to
measure LLD with more precision. For the lower extremity
scanogram, patients were supine on the radiographic table
with a radiopaque reference ruler. The x-ray tube was
centered precisely over the hip, knee, and ankle joints.
Three successive exposures of centered over the three joints
were performed. The result was a radiograph showing the
hips, knees, and ankles, but not the long bones (Fig 4). A
mathematic calculation was then used to determine a pos-
sible length difference between the contralateral limb seg-
ments. In patients who underwent periodic examinations
with lower extremity scanograms for follow-up of LLD, the
first scanogram was used for the LLD measurement to
eliminate the possible effect of treatment for CVM.
Study design. A clinically significant LLDwas defined
Fig 4. A lower extremity scanogram in which the x-ray tube is
centered precisely over the hip (top), knee (middle), and ankle
joints (bottom) and three successive exposures of the lower extrem-
ity centered over the three joints are performed. Leg length dis-
crepancy can be determined by the sum of length discrepancies in
the three segments.as a limb length difference of 2 cm identified by lowerextremity scanograms. Univariate and multivariate analyses
were performed to determine risk factors for the develop-
ment of clinically significant LLD. The variables for analysis
included age (still growing age group15 years vs finished
growing age group 15 years), sex, characteristics of the
CVM lesion (types, extent, and depth), joint involvement
of the CVM, and a coexisting deep venous abnormality
(agenesis, hypoplasia, phlebectasia) of the affected limb.
Subgroup analysis of the patients with LLD was performed
to determine any specific risk factors for overgrowth or
undergrowth of the affected limb.
Statistical analysis. For univariate analysis, the Fisher’s
exact test and 2 test were performed. For multivariate
analysis, logistic regression analysis was performed calculat-
ing the odds ratio (OR) and 95% confidence interval (95%
CI) for the risk for LLD (2 cm). For comparison between
LLD caused by overgrowth and undergrowth, the Fisher’s
exact test was used. A P  .05 was considered significant.
All statistical analyses were performed with SPSS 10.1
software (SPSS, Inc, Chicago, Ill).
RESULTS
For all patients with lower extremity CVM, the female-
to-male ratio was 1.4 and the mean age was 20.5 years
(range, 1 to 62 years). The features of each type of CVM are
described in Table I. The age distribution of patients
Table I. Characteristics of patients according to the type
of congenital vascular malformation
Type of CVM
AVM VM LM VLM
No. (%) 43 (12) 215 (60) 46 (13) 57 (16)
Male (%) 18 (42) 89 (41) 15 (33) 31 (54)
Age (y) mean  SD 27  13 21  14 20  15 15  12
(range) (5-54) (1-59) (1-62) (1-52)
Extent of CVM
Lower leg 18 (42) 67 (31) 24 (52) 9 (16)
Upper leg 5 (12) 49 (23) 11 (24) 8 (14)
Whole leg 20 (47) 99 (46) 11 (24) 40 (70)
Depth of CVM
Subcutaneous 12 (28) 64 (30) 44 (96) 25 (44)
Muscle 24 (56) 137 (64) 2 (4) 26 (46)
Bone 7 (16) 14 (7) 0 (0) 6 (11)
Ankle or knee joint
involved
No 41 (95) 202 (94) 46 (100) 53 (93)
Yes 2 (5) 13 (6) 0 (0) 4 (7)
Deep vein
Intact 33 (77) 184 (86) 45 (98) 52 (91)
Aplasia* 1 (2) 15 (7) 0 (0) 1 (2)
Hypoplasia† 0 (0) 4 (2) 0 (0) 3 (5)
Phlebectasia‡ 9 (21) 12 (6) 1 (2) 1 (2)
CVM, Congenital vascular malformation; AVM, arteriovenous malforma-
tion; VM, venous malformation; LM, lymphatic malformation; VLM, com-
bined venolymphatic malformation.
*Not detectable venous flow in a segment of deep vein.
†Diameter of a segment of deep vein 50% of adjacent vein diameter.
‡Diameter of a segment of deep vein 200% of adjacent vein diameter.showed that 157 patients (43%) were in the still growing
M, v
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growing age group (15 years). Fig 5 shows the distribu-
tion of LLD on scatter plots according to the age and types
of CVM. The overall frequency of a LLD 2 cm was 7.2%
(26 of 361) due to overgrowth (n 20) and undergrowth
(n  6) of the affected limbs. The frequencies of LLD by
the variables studied are shown in Table II.
By univariate analysis, the type and extent of the CVM
were identified as significant risk factors for LLD (P .003
and P  .001). However, multivariate analysis identified
only the extent of the CVM (whole leg involvement) as an
independent risk factor for LLD (P  .002) (Table III).
Multivariate analysis for LLD specifically due to over-
growth of the affected limb also identified the extent of
CVM (whole leg involvement) as an independent risk
factor (P  .004; OR, 6.512; 95% CI, 1.788 to 23.713)
(Table IV). Risk factor analysis for undergrowth (n  6)
did not have sufficient statistical power because of the small
Fig 5. Scatter plots show the distribution of leg length
congenital vascular malformation. The two dotted horizo
black squared dots above the upper horizontal line indica
horizontal line indicate LLD 2 cm by undergrowth o
vascular malformation; LM, lymphatic malformation; LVnumber of patients in this group. In a comparison betweentwo subgroups of patients with LLD (overgrowth group,
n 20 vs undergrowth group, n 6), all LLDs in females
were caused by overgrowth of the affected limb, whereas
60% (9 of 15) of LLDs in males were caused by overgrowth
(P  .022) (Table V).
DISCUSSION
An enhancement or reduction of leg bone growth has
been referred to as congenital vascular–bone syndrome in
patients with lower extremity CVM, and among various
clinical manifestations of lower extremity CVM, the pres-
ence of LLD is a serious sequela. The mechanism by which
abnormal limb growth occurs in patients with CVMs has
been investigated by many15,16 but remains incompletely
understood. The pathophysiology of abnormal bone
growth in patients with CVM is commonly ascribed to an
abnormal blood supply to the growth plate of the long
bone in the affected limb. Increased vascularization of the
epancy (LLD) according to the patient age and type of
ines indicate leg length discrepancy (LLD) of 2 cm. The
D 2 cm by overgrowth, and the dots below the lower
affected limb. AVM, Arteriovenous malformation; VM,
enolymphatic malformation.discr
ntal l
te LL
f thegrowth plate, and hypervascularity of intramedullary small
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ture, have been proposed to explain limb overgrowth.17
Bone overgrowth occurs not only in patients with AVM
but also in patients with other types of CVM. Venous
hypertension has been suggested as a cause of long bone
overgrowth in patients with CVM. Whether this results
from venous outflow obstruction or increased arterial in-
flow, as in an AVM, remains unclear. An animal study
reported elongation of the legs after ligation of the hindleg
vein in still growing, 1-month-old dogs.18 The pathogen-
esis of lower extremity bone overgrowth associated with
VMmay be explained by the opening of a normally existing
physiologic arteriovenous fistula. This serves as a compen-
satory mechanism for the impaired venous outflow in the
presence of deep venous aplasia or hypoplasia. In addition,
although some claim venous stasis or increased arterio-
venous flow causes limb overgrowth, repeated attempts to
change LLD with the creation of arteriovenous fistula or
ligation of deep veins were unsuccessful.
The mechanism for bone undergrowth in patients with
CVMs has also been explained by either mechanical or
hemodynamic (reduced circulation) causes.19 Mechanical
cause means a pressure effect on the metaphysis of long
Table II. Frequencies of leg length discrepancy 2 cm
Variable Limbs, n (%) LLD, n (%)
Age (year)
15 157 (43) 12 (8)
15 204 (57) 14 (7)
Sex
Male 153 (42) 15 (10)
Female 208 (58) 11 (5)
Type of CVM
LM 46 (13) 1 (2)
VLM 57 (16) 10 (18)
AVM 43 (12) 5 (12)
VM 215 (60) 10 (5)
Extent of CVM
Lower leg 118 (33) 3 (3)
Upper leg 73 (20) 1 (1)
Whole leg 170 (47) 22 (13)
Depth of CVM
Subcutaneous 145 (40) 8 (6)
Muscle 189 (52) 14 (7)
Bone 27 (7) 4 (15)
Joint involved
No 342 (95) 25 (7)
Yes 19 (5) 1 (5)
Deep vein
Intact 314 (87) 22 (7)
Aplasia* 17 (5) 2 (12)
Hypoplasia† 7 (2) 1 (14)
Phlebectasia‡ 23 (6) 1 (4)
LLD, Leg length discrepancy; CVM, congenital vascular malformation; LM
arteriovenous malformation; VM, venous malformation.
*Not detectable venous flow in a segment of deep vein.
†Diameter of a segment of deep vein 50% of adjacent vein diameter.
‡Diameter of a segment of deep vein 200% of adjacent vein diameter.bone and reduced perfusion to the bone occurs owing tothe steal effect in an AVM lesion.16,19 Based on the hemo-
dynamic hypothesis of abnormal bone growth, Belov and
Loose20 described that the surgical treatment for lower
extremity CVM should target the underlying vascular de-
fects.
In healthy subjects, the lower limb has a predictable
growth cycle of a strong increase in growth during the first
5 years of life, steady and slower growth from age 5 years to
the beginning of puberty, a slight growth spurt with an
accelerated velocity of growth at the beginning of puberty,
and early cessation of growth after the velocity peak.21,22 A
general clinical rule used to predict the size of LLD is that
the younger the patient when LLD is diagnosed, the
greater the LLD is likely to be at the end of bone growth.23
In patients with lower extremity CVM, however, the pre-
diction of LLD may not follow a predictable curve, and
results are more difficult to predict.
Considering that the growth of the lower extremity
bone is completed at about age 15, we compared the
distribution of LLDs in two different age groups, still
growing (15 years of age) and finished growing (15
years of age) age groups. The frequency of LLD in our
study was not different between these two age groups.
Cause of LLDs
Overgrowth (n  20, 77%) Undergrowth (n  6, 23%)
9 (75) 3 (25)
11 (79) 3 (21)
9 (60) 6 (40)
11 (100) 0
1 (100) 0
6 (60) 4 (40)
5 (100) 0
8 (80) 2 (20)
2 (67) 1 (33)
1 (100) 0
17 (77) 5 (23)
7 (88) 1 (12)
11 (79) 3 (21)
2 (50) 2 (50)
19 (76) 6 (24)
1 (100) 0
16 (73) 6 (27)
2 (100) 0
1 (100) 0
1 (100) 0
hatic malformation; VLM, combined venolymphatic malformation; AVM,, lympAssuming that the long bone growth is influenced by the
JOURNAL OF VASCULAR SURGERY
Volume 44, Number 3 Kim et al 551amount of blood perfusion to the growth plate at the long
bone epiphysis, we included the type, extent, and depth of
the CVM lesion as variables for the risk factor analysis, but
again, only the extent of the CVM lesion predicted LLD.
According to previous reports, AVM is the most com-
mon type of CVM that results in long bone hypertrophy or
overgrowth.19,24 Szilagyi et al25 reported LLDs in 24.3% of
patients with lower extremity AVM. Mattassi19 reported
bone hypertrophy in 32% (46% in AVM, 19% in VM, and
50% in VLM) and bone hypotrophy in 6% (4% in AVM and
7% in VM) of lower extremity CVM patients. Additionally,
Belov24 reported that 82% of LLD patients with lower
extremity CVM was due to bone overgrowth and 18% was
due to bone undergrowth. Klippel-Trenaunay syndrome is
a combined type of lower extremity CVM with VM, LM,
capillary malformation (port-wine skin lesion), and limb hy-
pertrophy, and Gloviczki et al26 reported lower extremity
overgrowth in 66% of Klippel-Trenaunay syndrome pa-
tients.
The depth of the CVM lesion can be easily determined
Table III. Risk factor analysis for leg length discrepancy
2 cm
Univariate
analysis Multivariate analysis‡
Variable P OR (95% CI) P
Age (year)
15 .776* 1
15 0.922 (0.375-2.268) .86
Gender
Female .101* 1
Male 1.715 (0.720-4.085) .223
Type of CVM
LM .003† 1
VLM 3.527 (0.373-13.313) .271
AVM 3.740 (0.348-20.214) .276
VM 1.143 (0.121-10.821) .907
Extent of CVM
Upper/lower leg .001* 1
Whole leg 5.856 (1.888-18.169) .002
Depth of CVM .227†
Subcutaneous 1
Muscle 1.304 (0.476-3.572) .606
Bone 2.730 (0.604-12.332) .192
Joint involved
No .595† 1
Yes 0.387 (0.042-3.592) .404
Deep vein
Intact .716† 1
Aplasia§ 1.428 (0.268-7.616) .676
Hypoplasia** 1.345 (0.131-13.775) .803
Phlebectasia†† 0.276 (0.030-2.560) .257
OR, Odds ratio; CI, confidence interval; CVM, congenital vascular malfor-
mation; LM, lymphatic malformation; VLM, combined venolymphatic mal-
formation; AVM, arteriovenous malformation; VM, venous malformation.
*2 test.
†Fisher’s exact test.
‡Logistic regression model.
§Not detectable venous flow in a segment of deep vein.
**Diameter of a segment of deep vein 50% of adjacent vein diameter.
††Diameter of a segment of deep vein 200% of adjacent vein diameter.by MRI. Additionally, CVM involving bone or joint spacecan be detected by adjunctive imaging procedures such as
arteriography or direct puncture phlebography as well as
MRI. Most of the LM lesions examined in this study were
confined to subcutaneous tissue, and 16% of AVMs were
identified to involve lower extremity bone. Assuming that
CVM lesions close to the epiphyseal plate may have a
greater influence on long bone growth, we examined bone
or joint involvement as variables. Neither the depth of
CVM lesion nor joint involvement was shown to be a
significant factor for LLD in both univariate and multivar-
iate analyses.
Some authors18 have attributed lower extremity bone
overgrowth to venous hypertension, and deep venous phle-
bectasia was reported as the most common feature of bone
undergrowth in patients with lower extremity CVM.24 We
found, however, that phlebectasia was more common in
patients with AVM, and our results did not support a
relationship between the deep venous abnormality and
LLD. Interestingly, we found that LLD in females was
more commonly associated with lower extremity over-
Table IV. Risk factor analysis for overgrowth 2 cm of
lower extremity bone
Univariate Multivariate‡
Variable P OR (95% CI) P
Age (year) .880*
15 1
15 0.780 (0.285-2.136) .629
Gender .737*
Female 1
Male 1.043 (0.397-2.740) .932
Type of CVM .035†
LM 1
VLM 2.425 (0.238-14.738) .455
AVM 4.625 (0.423-20.548) .209
VM 0.997 (0.101-9.888) .998
Extent of CVM .001*
Upper/lower leg 1
Whole leg 6.512 (1.788-23.713) .004
Depth of CVM .798†
Subcutaneous 1
Muscle 1.079 (0.361-3.223) .892
Bone 1.337 (0.200-8.938) .764
Joint involved 1.000†
No 1
Yes 0.740 (0.075-7.305) .797
Deep vein .499†
Intact 1
Aplasia§ 1.998 (0.364-10.950) .425
Hypoplasia** 1.935 (0.191-19.636) .577
Phlebectasia†† 0.371 (0.039-3.548) .39
OR, Odds ratio; CI, confidence interval; CVM, congenital vascular malfor-
mation; LM, lymphatic malformation; VLM, combined venolymphatic mal-
formation; AVM, arteriovenous malformation; VM, venous malformation.
*2 test.
†Fisher’s exact test.
‡Logistic regression model.
§Not detectable venous flow in a segment of deep vein.
**Diameter of a segment of deep vein 50% of adjacent vein diameter.
††Diameter of a segment of deep vein 200% of adjacent vein diameter.growth than in males (P  .022). However, multivariate
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CVM) as only a risk factor for LLD secondary to over-
growth of the affected limb.
Common methods of detecting LLD include direct
(tape measure methods), indirect (pelvic leveling), and
radiologic techniques. The options for measuring LLD
with more precision include lower extremity scanogram,
teleroentgenogram, CT scan/digital localization image,
and microdose digital scan.27 The lower extremity
scanogram was developed to minimize measurement
error due to magnification by the x-ray projection angle.
Although scanography is known as the most accurate
radiographic technique for measurement of LLD, prob-
lems with interpretation can result from calculation or
measurement errors in patients with significant limb length
inequalities or hip or knee joint contracture. In addition,
lower extremity scanography is not performed with the pa-
tient in a standing position; therefore, joint narrowing or
instability may go unnoticed in the supine position. Instead
of using the scanogram, some authors recommend full-
length standing anteroposterior radiography to determine
Table V. Comparison of variables between overgrowth
and undergrowth
Variable
Overgrowth
(n  20)
Undergrowth
(n  6) P*
Age (year) 1.000
15 9 3
15 11 3
Gender .022
Female 11 0
Male 9 6
Type of CVM .325
LM 1 0
VLM 6 4
AVM 5 0
VM 8 2
Extent of CVM .787
Upper/lower leg 3 1
Whole leg 17 5
Depth of CVM .34
Subcutaneous 7 1
Muscle 11 3
Bone 2 2
Joint involved 1.000
No 19 6
Yes 1 0
Deep vein .701
Intact 16 6
Aplasia† 2 0
Hypoplasia‡ 1 0
Phlebectasia§ 1 0
CVM, congenital vascular malformation; LM, lymphatic malformation;
VLM, combined venolymphatic malformation;AVM, arteriovenous malfor-
mation; VM, venous malformation.
*Fisher’s exact test.
†Not detectable venous flow in a segment of deep vein.
‡Diameter of a segment of deep vein 50% of adjacent vein diameter.
§Diameter of a segment of deep vein 200% of adjacent vein diameter.LLD.28CONCLUSION
Among lower extremity CVM patients, 7% showed a
clinically significant LLD, and the extent of the CVM lesion
(whole leg involvement of CVM) was the single indepen-
dent risk factor for LLD regardless the type or depth of the
CVM lesion. Our data also suggest that the cause of LLD,
either overgrowth or undergrowth, of the affected limb
might be related to gender. Although the types of CVMdid
not show any significant influence on the development of
LLD in our data, we believe that classification of CVM has
an important role in understanding the behavior of the
vascular lesion, predicting complications or sequela, and in
determining an optimal management strategy for CVM
patients. In addition, to predict the LLD in pediatric pa-
tients with leg CVM, normal bone growth as well as the risk
factors for LLD should be considered together.
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